Exploring the link between diabetic complications and obstructive sleep apnea
Diabetic Complications and Obstructive Sleep Apnea in Type 2 Diabetic Patients: A Longitudinal Study
This study looks at how obstructive sleep apnea affects the health of people with type 2 diabetes and their risk of developing complications.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 330 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | The First Affiliated Hospital of Xiamen University Academic / other |
| Locations | 1 site (Xiamen, Fujian) |
| Trial ID | NCT04646941 on ClinicalTrials.gov |
What this trial studies
This observational study follows patients with type 2 diabetes to investigate the relationship between obstructive sleep apnea (OSA) and the progression of chronic complications associated with diabetes. The study involves anthropometric measurements, laboratory testing, and standard overnight polysomnography monitoring conducted from 2013 to 2018. By analyzing data collected from these assessments, researchers aim to better understand how OSA impacts diabetic patients' health outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-80 diagnosed with type 2 diabetes.
Not a fit: Patients with non-type 2 diabetes, severe cardiovascular disease, or those who are pregnant or lactating may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for diabetic patients with obstructive sleep apnea, potentially reducing complications.
How similar studies have performed: Other studies have indicated a significant prevalence of obstructive sleep apnea in type 2 diabetes patients, suggesting that this research could build on established findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Type 2 diabetes * Age：18-80 Exclusion Criteria: * Patients with non type 2 diabetes mellitus * Preparation for pregnancy * Lactation patients * Patients with uncontrolled thyroid disease * Patients with severe cardiovascular disease * Patients with severe hepatic and renal insufficiency * Patients with oral and maxillofacial malformations and upper respiratory tract malformations * Patients with pulmonary infection or COPD * Patients who are not willing to accept the questionnaire survey * Unable to sign informed consent
Where this trial is running
Xiamen, Fujian
- The first affiliated hospital of Xiamen university — Xiamen, Fujian, China (Recruiting)
Study contacts
- Study coordinator: Changqin Liu, Dr.
- Email: liuchangqin@xmu.edu.cn
- Phone: +86-592-2137796
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.